Commonwealth Equity Services’s Aptose Biosciences, Inc. APTO Stock Holding History

Commonwealth Equity Services’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23	Closed	-$57K	–	2999
2019 Q4	$57K	Buy	+23	New	+$30K	﹤0.01%	2790
2018 Q3	–	Sell	-25	Closed	-$45K	–	2879
2018 Q2	$45K	Buy	+25	New	+$39.9K	﹤0.01%	2667

Other funds holding APTO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services's APTO Position: Q1 2020 in Review

Commonwealth Equity Services sold out of Aptose Biosciences, Inc. (APTO) in Q1 2020, closing a stake of 23 shares — an estimated $57K sold.

Commonwealth Equity Services first reported a position in APTO in Q2 2018 and held it in 2 quarters. The position peaked at $57K in Q4 2019. 51 funds tracked by Wall St. Rank hold APTO as of Q1 2020.

Commonwealth Equity Services reported no remaining Aptose Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
Commonwealth Equity Services sold 23 Aptose Biosciences, Inc. shares in Q1 2020, an estimated $57K.
Commonwealth Equity Services first reported a position in Aptose Biosciences, Inc. in Q2 2018 and held it in 2 quarters.
Commonwealth Equity Services's Aptose Biosciences, Inc. position peaked at $57K in Q4 2019.
51 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2020.

Based on Commonwealth Equity Services's 13F filing for Q1 2020, filed 11 May 2020.